Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
C2.1.D_NGI |
By Age: <15 |
2015 |
2,430 |
C2.1.D_NGI |
By Age: 15+ |
2015 |
24,570 |
C2.1.D_NGI |
By Age/Sex: <15 Female |
2015 |
1,775 |
C2.1.D_NGI |
By Age/Sex: <15 Male |
2015 |
655 |
C2.1.D_NGI |
By Age/Sex: 15+ Female |
2015 |
17,199 |
C2.1.D_NGI |
By Age/Sex: 15+ Male |
2015 |
7,371 |
C2.1.D_NGI |
By Sex: Female |
2015 |
18,900 |
C2.1.D_NGI |
By Sex: Male |
2015 |
8,100 |
C2.1.D_NGI |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
27,000 |
C2.1.D_NGI |
Sum of Age disaggregates |
2015 |
27,000 |
C2.1.D_NGI |
Sum of Age/Sex disaggregates |
2015 |
27,000 |
C2.1.D_NGI |
Sum of Sex disaggregates |
2015 |
27,000 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
1,332 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
490 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
12,900 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
5,528 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
20,250 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
20,250 |
CARE_NEW |
Aggregated Age/sex: <15 Female |
2015 |
592 |
CARE_NEW |
Aggregated Age/sex: <15 Male |
2015 |
218 |
CARE_NEW |
Aggregated Age/sex: 15+ Female |
2015 |
5,733 |
CARE_NEW |
Aggregated Age/sex: 15+ Male |
2015 |
2,457 |
CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
9,000 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2015 |
9,000 |
CARE_SITE |
By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
22 |
CARE_SITE |
Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
22 |
CARE_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
22 |
CARE_SITE |
Total number of PEPFAR supported sites providing clinical care services |
2015 |
22 |
LAB_CAP |
By Point-of-care testing sites |
2015 |
22 |
LAB_CAP |
By site support type: Technical Assistance-only (TA) |
2015 |
22 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
22 |
LAB_CAP |
Sum of Site Support Type disaggregates |
2015 |
22 |
QI_SITE |
By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months |
2015 |
15 |
QI_SITE |
By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
22 |
QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
15 |
QI_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
15 |
QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
22 |
QI_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
22 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
22 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
22 |
SITE_SUPP |
By program area/support type: Lab Technical Assistance-only (TA) |
2015 |
22 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
22 |
TX_CURR |
Aggregated Age/Sex: <1 Female |
2015 |
36 |
TX_CURR |
Aggregated Age/Sex: <1 Male |
2015 |
36 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
784 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
290 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
7,598 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
3,256 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
12,000 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
1,074 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
10,854 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
11,928 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Female |
2015 |
36 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Male |
2015 |
36 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Female |
2015 |
784 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Male |
2015 |
290 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Female |
2015 |
7,598 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Male |
2015 |
3,256 |
TX_CURR_NGI |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
12,000 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex <15 |
2015 |
1,074 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex 15+ |
2015 |
10,854 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex disaggregates |
2015 |
11,928 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
4,400 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
11,000 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
16,000 |
TX_SITE |
By support type: Technical Assistance (TA-only): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
22 |
TX_SITE |
By support type: Technical Assistance (TA-only): Total number of PEPFAR-supported ART sites |
2015 |
22 |
TX_SITE |
Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
22 |
TX_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
22 |
TX_SITE |
Total number of PEPFAR-supported ART sites |
2015 |
22 |
TX_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
22 |